American College of Cardiology (ACC)

The American College of Cardiology (ACC) is the primary U.S. medical society representing the interests of all cardiology subspecialities. The ACC is very active in setting guidelines for cardiac care, lobbying for supportive government policy and reimbursements, clinician education, managing several key cardiovascular registries and advocating for the transformation of cardiovascular care to improve heart health.

SCAI President Sunil Rao, MD, explains the 2022-2023 SCAI accomplishments to improve interventional cardiology.

SCAI President Sunil Rao on how the society is helping advance interventional cardiology

Rao spoke with Cardiovascular Business at ACC.23 to detail some of SCAI's biggest accomplishments from the last year. 

SCAI President Sunil Rao explains what he saw as the top 5 interventional studies at ACC23. #SCAI #ACC #ACC23

5 studies that could make a big impact on interventional cardiology

SCAI President Sunil Rao, MD, spoke with us about some of the key interventional cardiology studies presented at ACC.23 in New Orleans. 

Echocardiography expert Patricia A. Pellikka, MD, discussed the trend of increasing artificial intelligence (AI) integration in cardiac ultrasound with Cardiovascular Business at American College of Cardiology (ACC) 2023 meeting.

AI's growing impact on echocardiography

Cardiology has the second largest number of FDA-cleared AI algorithms, and many of them are for cardiac ultrasound. Echocardiography expert Patricia A. Pellikka, MD, discusses this trend and how AI is helping improve echo.

Atul Verma explains thne results of the PULSE-AF trial at ACC23.

Pulsed-field ablation could be the next big EP technology trend

Atul Verma, MD, director of cardiology at McGill University Health Centre in Montreal, explained why the late-breaking PULSED-AF trial data on Medtronic’s pulsed-field ablation technology is so important for cardiologists. 

ACC Vice President Cathie Biga discusses OBLs and ASCs during the ACC23 meeting. #ACC #OBLs #ASCs #ACC23

What the rise of outpatient cardiac OBLs and ASCs means for cardiology

To reduce the healthcare costs associated with straightforward, minimally invasive cardiovascular procedures, more and more ambulatory surgical centers and office based labs are opening all over the United States.

ACC Vice President Cathie Biga explains issues with cardiology reimbursements at ACC23. #ACC #ACC23

Reimbursement challenges raising concerns in cardiology

Cathie Biga, vice president of the American College of Cardiology, spoke to Cardiovascular Business at ACC.23 about challenges in the world of cardiology reimbursements. "As that healthcare dollar goes up, it is not going to the physicians," she said.

Example of an FFR-angio image-derived hemodynamic flow model performed tableside in the cath lab reconstructed using three different C-arm contract image acquisitions. This technology from CathWorks, which was recently acquired by Medtronic, can eliminate the need for pressure wires and adenosine to assess FFR pressures. These measurements are used to determine the hemodynamic significance of a stenosis and determine if a stent is necessary or if a patient can be treated medically.

PHOTO GALLERY: ACC.23 in New Orleans

Browse a selection of photos from the American College of Cardiology's annual meeting in New Orleans. The pictures highlight key moments, new technologies and much more from the big show. 

Steven Nissen, MD, chief academic officer of the Heart, Vascular and Thoracic Institute, Cleveland Clinic, explains the details from the late-breaking CLEAR Outcomes trial presented at the 2023 American College of Cardiology (ACC) meeting found bempedoic acid can be used in statin-intolerant patients to reduce low-density lipoprotein (LDL) cholesterol levels. #ACC #ACC23 Nexletol

CLEAR Outcomes trial shows statin-intolerant patients benefit from bempedoic acid

Steven Nissen, MD, spoke with Cardiovascular Business at ACC.23 about the late-breaking CLEAR Outcomes trial.